Chlamydial Antiapoptotic Activity Involves Activation of the Raf/MEK/ERK Survival Pathway

被引:27
|
作者
Du, Kun [1 ]
Zheng, Qun [1 ]
Zhou, Ming [1 ]
Zhu, LiSha [1 ]
Ai, Biao [1 ]
Zhou, Li [1 ]
机构
[1] Yangtze Univ, Affiliated Hosp 1, Dept Clin Lab, Jinzhou 434000, Hubei, Peoples R China
关键词
TRACHOMATIS-INFECTED CELLS; PROAPOPTOTIC PROTEINS; TRANSCRIPTION FACTORS; HIPPOCAMPAL-NEURONS; UP-REGULATION; APOPTOSIS; HOST; DEGRADATION; DEATH; CASPASES;
D O I
10.1007/s00284-011-9985-2
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Chlamydiae are obligate intracellular bacteria that cause variety of human diseases. Chlamydia-infected host cells are profoundly resistant to apoptosis induced by many different apoptotic stimuli. The inhibition of apoptosis is thought to be an important immune escape mechanism allowing chlamydiae to productively complete their obligate intracellular growth cycle. Infection with chlamydiae can activate the Raf/MEK/ERK pathway. Because the survival pathway can modulate apoptosis, we used MEK-specific inhibitor U0126 and Raf-specific inhibitor GW5074 to examine the role of Raf/MEK/ERK pathway in chlamydial antiapoptotic activity. Apoptosis was induced by staurosporine (STS) and detected by morphology, DNA fragmentation, caspase-3 activation, and poly (ADP-ribose) polymerase cleavage. Inhibition of the pathway sensitized Chlamydia-infected cells to STS-mediated cell apoptosis. The data indicate that chlamydial antiapoptotic activity involves activation of the Raf/MEK/ERK survival pathway.
引用
收藏
页码:341 / 346
页数:6
相关论文
共 50 条
  • [41] Docetaxel cytotoxicity is enhanced by inhibition of the Raf/MEK/ERK signal transduction pathway
    Navolanic, PM
    Lee, JT
    McCubrey, JA
    CANCER BIOLOGY & THERAPY, 2003, 2 (06) : 677 - 678
  • [42] Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions
    Kolch, W
    BIOCHEMICAL JOURNAL, 2000, 351 : 289 - 305
  • [43] Role of Raf kinase in cancer: Therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway
    Gollob, Jared A.
    Wilhelm, Scott
    Carter, Chris
    Kelley, Susan L.
    SEMINARS IN ONCOLOGY, 2006, 33 (04) : 392 - 406
  • [44] Analysis of the ERK Pathway Cysteinome for Targeted Covalent Inhibition of RAF and MEK Kinases
    Romany, Aarion
    Liu, Ruibin
    Zhan, Shaoqi
    Clayton, Joseph
    Shen, Jana
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2023, 63 (08) : 2483 - 2494
  • [45] Modulation of the Ras/Raf/MEK/ERK pathway by Ca2+, and calmodulin
    Agell, N
    Bachs, O
    Rocamora, N
    Villalonga, P
    CELLULAR SIGNALLING, 2002, 14 (08) : 649 - 654
  • [46] Comprehensive genetic analysis of overlapping syndromes of RAS/RAF/MEK/ERK pathway
    Tumurkhuu, Munkhtuya
    Saitoh, Makiko
    Sato, Atsushi
    Takahashi, Kan
    Mimaki, Masakazu
    Takita, Junko
    Takeshita, Kazuhide
    Hama, Takehiro
    Oka, Akira
    Mizuguchi, Masashi
    PEDIATRICS INTERNATIONAL, 2010, 52 (04) : 557 - 562
  • [47] Porcine deltacoronavirus activates the Raf/MEK/ERK pathway to promote its replication
    Jeon, Ji Hyun
    Lee, Yoo Jin
    Lee, Changhee
    VIRUS RESEARCH, 2020, 283
  • [48] Regulation of MEK/ERK pathway output by subcellular localization of B-Raf
    Andreadi, Catherine
    Noble, Catherine
    Patel, Bipin
    Jin, Hong
    Hernandez, Maria M. Aguilar
    Balmanno, Kathryn
    Cook, Simon J.
    Pritchard, Catrin
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2012, 40 : 67 - 72
  • [49] Rational targeting of the Raf-MEK-ERK pathway in colorectal cancer using MEK inhibitor therapy
    Yeh, J.
    Routh, E. D.
    Kim, H. J.
    Der, C. J.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) : 36 - 36
  • [50] Paradoxical activation of the RAF-MEK-ERK pathway in response to nilotinib induces synthetic lethality with MEK inhibition in head and neck cancer cells
    Sen, Banibrata
    Mazumdar, Tuhina
    Peng, Shaohua
    Hale, Katherine S.
    Glisson, Bonnie S.
    Johnson, Faye M.
    CANCER RESEARCH, 2013, 73 (08)